Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 8-K Event Executive or director change · Shareholder vote results
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. DEF 14A Proxy Proxy Statement
  9. SC 13G Stake Amended Statement of Ownership
  10. 8-K Event Regulation FD disclosure
  11. SC 13G Stake Amended Statement of Ownership
  12. 424B5 Offering Prospectus
  13. 8-K Event Material agreement · Other events
  14. 8-K Event Regulation FD disclosure
  15. 424B5 Offering Prospectus
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 42 of 68 · 1,358 filings